Theoretical and Natural Science

- The Open Access Proceedings Series for Conferences


Theoretical and Natural Science

Vol. 6, 03 August 2023


Open Access | Article

Global status of antibiotic resistance and management

Lei Chan * 1
1 Anhui Medical University

* Author to whom correspondence should be addressed.

Theoretical and Natural Science, Vol. 6, 340-345
Published 03 August 2023. © 2023 The Author(s). Published by EWA Publishing
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Citation Lei Chan. Global status of antibiotic resistance and management. TNS (2023) Vol. 6: 340-345. DOI: 10.54254/2753-8818/6/20230276.

Abstract

The greatest achievement of the 20th century is the invention and use of antibiotics. However, the abuse use of antibiotics caused by poor regulation has become an urgent issue worldwide, and has risen to be a threat to the global public health, bringing a great financial burden on society. From the perspective of the world, the United States has a long history of development in the discovery, application and regulatory process of antibiotics, forming sufficient cognition and relatively perfect countermeasures. Although the European Union and its member states started the measures to curb antibiotic resistance late, they also caught up and gradually established a complete monitoring system. As the largest developing country, China still has a lot to work on, especially the construction of basic medical facilities and systems. It can be seen that the importance of antibiotics use and management have become a global consensus. This article elaborated and focus the current situation of antibiotic resistance in the United States, the European Union and China as well as the corresponding countermeasures taken by each country. Countries should collaborate together and establish a global system to monitor the use of antibiotics in order to control antibiotic resistance.

Keywords

antibiotic resistance, global health, management strategies

References

1. Uddin, Tanvir Mahtab, et al. "Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects." Journal of infection and public health 14.12 (2021): 1750-1766.

2. Centers for Disease Control and Prevention. Antibiotic resistance threats in the United States, 2019. US Department of Health and Human Services, Centres for Disease Control and Prevention, 2019.

3. Böttcher, Helmuth Maximilian. Wonder drugs: A history of antibiotics. Lippincott, 1964.

4. Levy, Stuart B. "Emergence of antibiotic-resistant bacteria in the intestinal flora of farm inhabitants." The Journal of infectious diseases 137.5 (1978): 688-690.

5. FDA Task Force, Antibiotics in Animal Feeds, Report to the Commissioner of the Food and Drug Administration, Maryland: Food and Drug Administration,1972, p.8,p.10.

6. FDA Center for Veterinary Medicine, “CVM Concerns about Antimicrobial Use in Food Animal”, FDA Veterinarian, 1998(4): 1-4.

7. World Health Organization. Antimicrobial resistance global report on surveillance: 2014 summary. No. WHO/HSE/PED/AIP/2014.2. World Health Organization, 2014.

8. World Health Organization. "Global action plan on antimicrobial resistance." (2015).

9. Sean Esteban McCabe,Timothy E. Wilens,Carol J. Boyd,Kao-Ping Chua,Terri Voepel-Lewis,Ty S. Schepis. Age-specific risk of substance use disorders associated with controlled medication use and misuse subtypes in the United States[J]. Addictive Behaviors,2019,90.

10. EFSA, ECDC. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014[J]. EFSA J, 2016, 14(2): 4036-4036.

11. EFSA, ECDC. The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2016[J]. EFSA J, 2018, 16(2): 5182.

12. Gilchrist, Mark, et al. "Antimicrobial stewardship from policy to practice: experiences from UK antimicrobial pharmacists." Infectious diseases and therapy 4 (2015): 51-64.

13. Hand, Kieran. "Antibiotic pharmacists in the ascendancy." Journal of Antimicrobial Chemotherapy 60.suppl_1 (2007): i73-i76.

14. Struwe, Johan. "Fighting antibiotic resistance in Sweden-past, present and future." Wiener klinische Wochenschrift 120 (2008).

Data Availability

The datasets used and/or analyzed during the current study will be available from the authors upon reasonable request.

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. Authors who publish this series agree to the following terms:

1. Authors retain copyright and grant the series right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this series.

2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the series's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this series.

3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See Open Access Instruction).

Volume Title
Proceedings of the International Conference on Modern Medicine and Global Health (ICMMGH 2023)
ISBN (Print)
978-1-915371-65-2
ISBN (Online)
978-1-915371-66-9
Published Date
03 August 2023
Series
Theoretical and Natural Science
ISSN (Print)
2753-8818
ISSN (Online)
2753-8826
DOI
10.54254/2753-8818/6/20230276
Copyright
03 August 2023
Open Access
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited

Copyright © 2023 EWA Publishing. Unless Otherwise Stated